These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26810628)

  • 1. Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.
    Kessler RC; van Loo HM; Wardenaar KJ; Bossarte RM; Brenner LA; Ebert DD; de Jonge P; Nierenberg AA; Rosellini AJ; Sampson NA; Schoevers RA; Wilcox MA; Zaslavsky AM
    Epidemiol Psychiatr Sci; 2017 Feb; 26(1):22-36. PubMed ID: 26810628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of predictive analytics to provide clinical decision support in depression treatment planning.
    Kessler RC
    Curr Opin Psychiatry; 2018 Jan; 31(1):32-39. PubMed ID: 29076894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry.
    Kappelmann N; Rein M; Fietz J; Mayberg HS; Craighead WE; Dunlop BW; Nemeroff CB; Keller M; Klein DN; Arnow BA; Husain N; Jarrett RB; Vittengl JR; Menchetti M; Parker G; Barber JP; Bastos AG; Dekker J; Peen J; Keck ME; Kopf-Beck J
    BMC Med; 2020 Jun; 18(1):170. PubMed ID: 32498707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.
    Fonseka TM; MacQueen GM; Kennedy SH
    J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder.
    McIntyre RS; Suppes T; Tandon R; Ostacher M
    J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports.
    Kessler RC; van Loo HM; Wardenaar KJ; Bossarte RM; Brenner LA; Cai T; Ebert DD; Hwang I; Li J; de Jonge P; Nierenberg AA; Petukhova MV; Rosellini AJ; Sampson NA; Schoevers RA; Wilcox MA; Zaslavsky AM
    Mol Psychiatry; 2016 Oct; 21(10):1366-71. PubMed ID: 26728563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
    Mittal D; Fortney JC; Pyne JM; Wetherell JL
    J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.
    Lutz W; Stulz N; Köck K
    J Affect Disord; 2009 Nov; 118(1-3):60-8. PubMed ID: 19217669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.
    Craighead WE; Dunlop BW
    Annu Rev Psychol; 2014; 65():267-300. PubMed ID: 24405361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric major depressive disorder: neurobiology and implications for early intervention.
    Cullen K; Klimes-Dougan B; Kumra S; Schulz SC
    Early Interv Psychiatry; 2009 Aug; 3(3):178-88. PubMed ID: 22640381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive disorder in adolescence: a brief review of the recent treatment literature.
    Milin R; Walker S; Chow J
    Can J Psychiatry; 2003 Oct; 48(9):600-6. PubMed ID: 14631880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
    Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.